Bloodstream infections leading to sepsis are among the top 10 causes of mortality in the United States. It is commonly recognized that rapid identification and therapy can have a tremendous impact on patient recovery and hospital length of stay. Data collected over a five year period will be reviewed to demonstrate the impact of migrating from traditional microbiology methods to a rapid molecular diagnostic test, and the drivers behind the adoption of the ePlex® Blood Culture Identification Panels. Register for this event to learn more about the impact of rapid molecular diagnostic testing for bloodstream infections. |
Featured SpeakerKevin M. McNabb, PhD, MTDirector of Microbiology, Immunology and Molecular Testing Wilmington Pathology Associates, New Hanover Regional Medical Center |